Alcon (ALC) news
Recent news
Alcon AG: BTIG cuts target price to $74 from $82
BTIG analyst Ryan Zimmerman has revised the price target for Alcon AG (ALC) from $82 to $74, reflecting a 10% reduction in the firm's outlook for the stock. Despite this adjustment, the analyst has maintained a "Buy" rating for the stock, indicating continued confidence in its long-term potential .…
AInvest Wire · 3d agoLifecore Biomedical - Unit enters amendment no. 3 to contract manufacturing agreement with Alcon effective Nov 1, 2026 - SEC filing
AInvest Wire · Sep 29, 2026EU clears command Alkon acquisition
The European Commission has approved the acquisition of Alcon by Novartis, following a thorough review of the transaction's compliance with EU competition law. The decision confirms that the acquisition will not significantly impede competition in the European Economic Area. The Commission's…
AInvest Wire · Sep 23, 2026Alcon AG: Bernstein cuts target price to $92.35 from $94.20
Bernstein has revised its price target for Alcon AG (ALC), lowering it to $92.35 from the previous $94.20. The adjustment reflects the firm’s updated assessment of the company’s near-term outlook, despite ongoing product launches that have historically supported growth. While the firm acknowledges…
AInvest Wire · Sep 23, 2026Alcon CEO: US drug pricing deal won't lift prices in Europe
AInvest Wire · Sep 14, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.